Nucleic Acids Research, 1990, Vol. 18, No. 23 6863-6869
© 1990
Articles |
Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines
Dipartimento di Genetica e di Biologia dei Microrganismi, Università di Milano Milan, Italy 1Laboratory of Hematopoietic Growth Factors, New York Blood Center New York, NY, USA 2Istituto Superiore di Sanità Rome, Italy
*To whom correspondence should be addressed at Università degli Studi di Milano, Dipartimento di Genetica e di Biologia dei Microrganismi, Via Celoria, 26-10133 Milan, Italy
Received September 11, 1990. Revised October 26, 1990. Accepted November 26, 1990.
The transcriptional binding protein NFE-1 (also called GF-1 and Ery-f1) Is thought to play a necessary, but not sufficient, role in the regulation of differentiation-related gene expression in a subset of hematopoietic lineages (erythroid, megakaryocytlc, and basophil-mast cell). In order to clarify the mechanism which underlies the lineage-specificity of the NFE-1 expression, as well as the relationship between the expression of this factor and growth factor responsiveness, we have evaluated the capacity of erythropoietin (Epo)-, granulo-monocytic (GM)-colony stimulating factor (CSF)-, and granulocyte (G)-CSF-dependent subclones derived from the interleukin 3 (IL-3)-dependent cell line 32D, to express 1) NFE-1 mRNA, 2) NFE-1-related nuclear proteins, and 3) chloramphenicol acetyl transferase (CAT) activity when transfected with a CAT gene under the control of NFE-1 cognate sequences. NFE-1 mRNA was found to be expressed not only in cells with mast cell (IL-3-dependent 32p) and erythroid (Epo-dependent 32D Epo1) phenotypes, but also in cells with predominantly granulocyte/macrophage properties, such as the GM-CSF- (early myelomonocytlc) and G-CSF- (myelocytic) dependent subclones of 32D. However, a gradient of expression, correlating with the lineage, the stage of differentiation, and the growth factor responsiveness of the cell lines, was found among the different subclones: Epo
IL-3>GM-CSF>G-CSF. Binding experiments demonstrated NFE-1 activity in all cell lines except the G-CSF-dependent line. Function of the NFE-1 protein was assessed by the expression of the CAT gene linked to the SV40 promoter and a mutant (—175 T-C) HPFH 
-globin promoter. High level CAT expression was seen only in the Epo1 cells although low level expression was also seen in the parent 32D. These results demonstrate that the specificity of the expression of NFE-1 for the erythroid—megakaryocytic—mast cell lineages Is obtained by progressive inactivatlon of its expression in alternative llneages.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. R. Migliaccio, R. A. Rana, M. Sanchez, R. Lorenzini, L. Centurione, L. Bianchi, A. M. Vannucchi, G. Migliaccio, and S. H. Orkin GATA-1 as a Regulator of Mast Cell Differentiation Revealed by the Phenotype of the GATA-1low Mouse Mutant J. Exp. Med., February 3, 2003; 197(3): 281 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Delassus, I. Titley, and T. Enver Functional and Molecular Analysis of Hematopoietic Progenitors Derived From the Aorta-Gonad-Mesonephros Region of the Mouse Embryo Blood, September 1, 1999; 94(5): 1495 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Hu, D Krause, M Greaves, S Sharkis, M Dexter, C Heyworth, and T Enver Multilineage gene expression precedes commitment in the hemopoietic system. Genes & Dev., March 15, 1997; 11(6): 774 - 785. [Abstract] [PDF]
|
|
|
|
|
|
L. H. Hoefsloot, M. P. van Amelsvoort, L. C.A.M. Broeders, D. C. van der Plas, K. van Lom, H. Hoogerbrugge, I. P. Touw, and B. Lowenberg Erythropoietin-Induced Activation of STAT5 Is Impaired in the Myelodysplastic Syndrome Blood, March 1, 1997; 89(5): 1690 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Taxman and D. M. Wojchowski Erythropoietin-induced Transcription at the Murine beta[IMAGE]-Globin Promoter J. Biol. Chem., March 24, 1995; 270(12): 6619 - 6627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Pevny, C. Lin, V D'Agati, M. Simon, S. Orkin, and F Costantini Development of hematopoietic cells lacking transcription factor GATA-1 Development, January 1, 1995; 121(1): 163 - 172. [Abstract] [PDF]
|
|
|
|
|
|
S F Tsai, E Strauss, and S H Orkin Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes & Dev., June 1, 1991; 5(6): 919 - 931. [Abstract] [PDF]
|
|